ResearcherPusan National UniversityActive in the last 2 years
Nam Kyung Lee
Matched on ORCID iD 0000-0003-1972-2719; OpenAlex author ID A5049243607. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2020: 3 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Low prealbumin predicts early recurrence after pancreatic cancer surgery: a retrospective cohort study. Co-author DOI 10.21037/gs-2026-0156↗
- Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic cancer. Co-author DOI 10.14216/kjco.23003↗
- Meta-analysis of MRI for the diagnosis of liver metastasis in patients with pancreatic adenocarcinoma. Last author DOI 10.1002/jmri.26969↗
- Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. Co-author DOI 10.12998/wjcc.v8.i17.3718↗
- First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy. Co-author DOI 10.12998/wjcc.v8.i18.4022↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Seung Baek Hong · 5 shared papers, 2020–2026 · strength 0.82
- Paper Low prealbumin predicts early recurrence after pancreatic cancer surgery: a retrospective cohort study. DOI 10.21037/gs-2026-0156↗
- Paper Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic… DOI 10.14216/kjco.23003↗
- Paper Meta-analysis of MRI for the diagnosis of liver metastasis in patients with pancreatic adenocarcinoma. DOI 10.1002/jmri.26969↗
- Hyung Il Seo · 4 shared papers, 2020–2026 · strength 0.70
- Paper Low prealbumin predicts early recurrence after pancreatic cancer surgery: a retrospective cohort study. DOI 10.21037/gs-2026-0156↗
- Paper Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic… DOI 10.14216/kjco.23003↗
- Paper Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. DOI 10.12998/wjcc.v8.i17.3718↗
- Byeong Gwan Noh · 2 shared papers, 2023–2026 · strength 0.45
- Sung Yong Han · 3 shared papers, 2020–2023 · strength 0.43
- Paper Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic… DOI 10.14216/kjco.23003↗
- Paper Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. DOI 10.12998/wjcc.v8.i17.3718↗
- Paper First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combinat… DOI 10.12998/wjcc.v8.i18.4022↗
- Dong Uk Kim · 3 shared papers, 2020–2023 · strength 0.43
- Paper Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic… DOI 10.14216/kjco.23003↗
- Paper Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. DOI 10.12998/wjcc.v8.i17.3718↗
- Paper First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combinat… DOI 10.12998/wjcc.v8.i18.4022↗
- Byung Soo Park · 1 shared paper, 2026 · strength 0.27
- Myeong Hun Oh · 1 shared paper, 2026 · strength 0.27
- Chae Hwa Kwon · 1 shared paper, 2023 · strength 0.18
- Jin Hee Kim · 1 shared paper, 2020 · strength 0.13
- Sang Hyun Choi · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.